Network Pharmacology of Adaptogens in the Assessment of Their Pleiotropic Therapeutic Activity

16Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

The reductionist concept, based on the ligand–receptor interaction, is not a suitable model for adaptogens, and herbal preparations affect multiple physiological functions, revealing polyvalent pharmacological activities, and are traditionally used in many conditions. This review, for the first time, provides a rationale for the pleiotropic therapeutic efficacy of adaptogens based on evidence from recent gene expression studies in target cells and where the network pharmacology and systems biology approaches were applied. The specific molecular targets and adaptive stress response signaling mechanisms involved in nonspecific modes of action of adaptogens are identified.

Cite

CITATION STYLE

APA

Panossian, A., & Efferth, T. (2022, September 1). Network Pharmacology of Adaptogens in the Assessment of Their Pleiotropic Therapeutic Activity. Pharmaceuticals. MDPI. https://doi.org/10.3390/ph15091051

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free